Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Advanced Solid Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07686068
What this trial is testing

First-in-Human Trial of VBC106 in Participants With Advanced Solid Tumors

Who this might be right for
Participants With Advanced Solid Tumor Malignancies
VelaVigo Bio Inc 260
Testing effectiveness (Phase 2)Study completedNCT01457118
What this trial is testing

An Extension Study of NKTR-102 in Cancer Patients Previously Enrolled in NKTR-102 Studies

Who this might be right for
Malignant Solid Tumor
Nektar Therapeutics 27
Testing effectiveness (Phase 2)UnknownNCT06006390
What this trial is testing

CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors

Who this might be right for
Gastric CancerColon CancerRectal Cancer+4 more
Chongqing Precision Biotech Co., Ltd 60
Testing effectiveness (Phase 2)Looking for participantsNCT04969315
What this trial is testing

TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma

Who this might be right for
Renal Cell CancerCastrate Resistant Prostate CancerNon Small Cell Lung Cancer+1 more
Portage Biotech 35
Testing effectiveness (Phase 2)Looking for participantsNCT06292208
What this trial is testing

A Clinical Trial to Evaluate Effect of IBD0333 in Patients With Advanced Malignant Tumors

Who this might be right for
MTD
SUNHO（China）BioPharmaceutical CO., Ltd. 48
Early research (Phase 1)UnknownNCT05296772
What this trial is testing

Phase 1 First-in-human Study of JS014

Who this might be right for
Neoplasm MalignantNeoplasm, ExperimentalSolid Tumor, Adult+1 more
Anwita Biosciences 60
Early research (Phase 1)Study completedNCT01359982
What this trial is testing

Safety and Pharmacokinetic Study of RRx-001 in Cancer Subjects

Who this might be right for
Malignant Solid TumorLymphomas
EpicentRx, Inc. 26
Early research (Phase 1)Looking for participantsNCT05687136
What this trial is testing

Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmUnresectable Malignant Solid Neoplasm
National Cancer Institute (NCI) 66
Early research (Phase 1)UnknownNCT06501183
What this trial is testing

Anti-CDH17 CAR-T Cell Injection in Patients With CDH17-positive Advanced Malignant Solid Tumors

Who this might be right for
CDH17-positive Advanced Malignant Solid Tumors
Shanghai Pudong Hospital 17
Early research (Phase 1)Study completedNCT03238027
What this trial is testing

Investigate Axatilimab Alone or in Combination With Durvalumab in Patients With Solid Tumors

Who this might be right for
Solid TumorMetastatic TumorLocally Advanced Malignant Neoplasm+1 more
Syndax Pharmaceuticals 45
Early research (Phase 1)Looking for participantsNCT06120283
What this trial is testing

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorAdvanced Breast CancerMetastatic Breast Cancer+5 more
BeOne Medicines 433
Testing effectiveness (Phase 2)Study completedNCT04439214
What this trial is testing

Testing Nivolumab as a Potential Targeted Treatment in Cancers With Mismatch Repair Deficiency (MATCH-Subprotocol Z1D)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 47
Early research (Phase 1)Ended earlyNCT05737706
What this trial is testing

Study of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation

Who this might be right for
Solid TumorAdvanced Solid TumorNon-small Cell Lung Cancer+2 more
Mirati Therapeutics Inc. 63
Early research (Phase 1)UnknownNCT03986606
What this trial is testing

PSB205 in Subjects With Advanced Solid Tumors

Who this might be right for
Neoplasm Malignant
Qilu Puget Sound Biotherapeutics (dba Sound Biologics) 64
Early research (Phase 1)Ended earlyNCT03065387
What this trial is testing

Neratinib and Everolimus, Palbociclib, or Trametinib in Treating Participants With Refractory and Advanced or Metastatic Solid Tumors With EGFR Mutation/Amplification, HER2 Mutation/Amplification, or HER3/4 Mutation or KRAS Mutation

Who this might be right for
Advanced Malignant Solid NeoplasmEGFR Gene AmplificationEGFR Gene Mutation+7 more
M.D. Anderson Cancer Center 84
Not applicableLooking for participantsNCT05620732
What this trial is testing

Treatment of Advanced Malignant Solid Tumors With Claudin18.2CAR-T

Who this might be right for
Advanced Pancreatic CarcinomaAdvanced Gastric Carcinoma
Shenzhen University General Hospital 20
Early research (Phase 1)Ended earlyNCT00359294
What this trial is testing

A Phase I Study of Zalypsis (PM00104) in Subjects With Advanced Malignant Solid Tumors or Lymphoma

Who this might be right for
Solid TumorsLymphoma
PharmaMar 12
Early research (Phase 1)Looking for participantsNCT06126406
What this trial is testing

Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid Tumors

Who this might be right for
Gastric CancerColon CancerRectal Cancer+5 more
Chongqing Precision Biotech Co., Ltd 60
Early research (Phase 1)Looking for participantsNCT07600749
What this trial is testing

Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)

Who this might be right for
Malignant Neoplasm
Merck Sharp & Dohme LLC 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07785609
What this trial is testing

A Clinical Trial of MK-2010 With Sacituzumab Tirumotecan (Sac-TMT) in Participants With Solid Tumors (MK-2010)

Who this might be right for
Advanced Solid TumorsMalignant Neoplasm
Merck Sharp & Dohme LLC 200
Next Page